Gain- and loss-of-function analyses suggested that SNHG4 modulates cell senescence, the cell cycle, cell proliferation, the DNA damage response and enzalutamide resistance in PCa cells. This evidence concerns the gene SNHG4 and posterior cortical atrophy.